Formulation and Characterization of Drug Loaded Niosomal Gel for Anti-Inflammatory Activity
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32797
Formulation and Characterization of Drug Loaded Niosomal Gel for Anti-Inflammatory Activity

Authors: Sunil Kamboj, Vipin Saini, Suman Bala, Gaurav Sharma

Abstract:

The main aim of the present research was to encapsulate mefenamic acid in niosomes andincorporate the prepared niosomes in the carbopol gel base for sustained therapeutic action. Mefenamic acid loaded niosomes were prepared by thin film hydration technique and evaluated for entrapment efficiency, vesicular size and zeta potential. The entrapment efficiency of the prepared niosomes was found to increase with decreasing the HLB values of surfactants and vesicle size was found to increase with increasing the cholesterol concentration. Niosomal vesicles with good entrapment efficiencies were incorporated in carbopol gel base to form the niosomal gel. The prepared niosomal gel was evaluated for pH, viscosity, spreadability, extrudability and skin permeation study across the rat skin. The results of permeation study revealed that the gel formulated with span 60 niosomes sustained the drug release for 12h. Further the in vivo study showed the good inhibition of inflammation by the gel prepared with span 60 niosomes.

Keywords: Mefenamic acid, niosomal gel, nonionic surfactants, sustained release.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1089463

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 3678

References:


[1] F. U. Ijeoma, "Non-ionic surfactant based vesicles (niosomes) in drug delivery,” Int. J. Pharm., vol. 172, pp. 33-70, 1998.
[2] H. Schreir, "Liposomes and niosomes as topical drug carrier: Dermal and transdermal drug delivery,” J. Control. Rel., vol. 30, pp.1-15, 1994.
[3] A. J. Baillie, "The preparation and properties of niosomes nonionic surfactant vesicles,” J. Pharm. Pharmacol., vol. 37, pp.863-868, 1985.
[4] S. Roy, "Effect of method of preparation on chitosan microspheres of mefenamic acid,” Int. J. of Pharm. Sci. Drug Res., vol.1, no.1, pp.36-42, 2009.
[5] K. Srikanth, "Formulation and evaluation of topical meloxicam niosomal gel,” Indian J. Bio Pharm., vol. 1, pp. 7-13,2010.
[6] S.C. Chattaraj, "Physicochemical characterization of influenza viral vaccine loaded surfactant vesicles,” Drug Delivery, vol. 10, pp.73-77, 2003.
[7] N. Subramanian, "Spectrophotometric determination of tranexamic acid and mefenamic acid in tablet dosage form using derivation technique,” Int. J. Pharm. Biomed. Res., vol. 2, no. 1, pp. 26-29, 2011.
[8] H. Singh, "Development of UV spectrophotometric method for estimation of mefenamic acid in bulk and pharmaceutical dosage forms,” Int. J. Pharm. Pharma. Sci., vol. 3, no. 2, pp. 13-18, 2011.
[9] J. Y. Fang, "Effect of liposomes and niosomes on skin permeation of enoxacin,” Int. J. Pharm., vol. 219, pp. 61-72, 2001.
[10] R. A. R. Naresh,"Anti-inflammatory activity of niosomes encapsulated diclofenac sodium in arthritic rats,” Indian J. Pharmacol., vol. 26, pp. 46-48, 1994.